← All trials
NCT03485404
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2018
- Primary completion
- Mar 31, 2020
- Completion date
- May 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 2178
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Xijing HospitalLead sponsor
- Nanjing UniversityCollaborator
- Anhui Medical UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Jiao Tong UniversityCollaborator
- Xijing HospitalReponsible party - principal investigator
- Xijing HospitalStudy chair
- Shaanxi Provincial People's HospitalCollaborator
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.